Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors.
Mauricio A CuellarFacultad de Farmacia, Escuela de Química y Farmacia, Universidad de Valparaíso, Valparaíso 2340000, Chile.ORCID 0000-0003-3162-5364
Jessica MejíaDepartamento de Ciencias Vegetales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
Helena Quintero-PertuzDepartamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380000, Chile.ORCID 0000-0001-9706-5959
Alejandro Castro-ÁlvarezDepartamento de Ciencias Preclínicas, Facultad de Medicina, Universidad de La Frontera, Temuco 4780000, Chile.ORCID 0000-0001-8360-8027
Marco MelladoCentro de Investigación en Ingeniería de Materiales, Universidad Central de Chile, Santiago 8330507, Chile.ORCID 0000-0001-9577-5180
Waleska Vera-QuezadaFacultad de Farmacia, Escuela de Química y Farmacia, Universidad de Valparaíso, Valparaíso 2340000, Chile.ORCID 0000-0002-9965-9563
Gloria MontenegroDepartamento de Ciencias Vegetales, Facultad de Agronomía e Ingeniería Forestal, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.
Christian Espinosa-BustosDepartamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.ORCID 0000-0001-6038-8439
Raquel BridiDepartamento de Química Farmacológica y Toxicológica, Facultad de Ciencias Químicas y Farmacéuticas, Universidad de Chile, Santiago 8380000, Chile.ORCID 0000-0002-3891-5770
Cristian O SalasMedicinal Chemistry Laboratory, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.ORCID 0000-0001-7620-2459
Funding
Fondo Nacional de Desarrollo Científico y Tecnológico 1231199
6 · The paper itself
Abstract
Lichens are a source of diverse compounds with a wide range of biological activities, making them of significant interest for novel drug development. In this study, metabolites were extracted from
Indexed as
antibacterialsantioxidantsin silicolichen metabolitesPseudocyphellariaRecA protein
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Experimental and In Silico Studies to Unravel the Antioxidant and Antibacterial Properties of Lichen Metabolites from · full record | OpenQuestion